Ribon Therapeutics

📍 Cambridge, United States🗓 Founded 2015👥 70 employees💰 Last funded Jul 2021
Biotechnology Research🌐 ribontx.com
Website LinkedIn
Ribon is a clinical-stage biotechnology company dedicated to the discovery and development of first-in-class small molecule inhibitors to block the fundamental ability of cancer cells to survive under stress.
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2015
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Canada
1
Investor activity2019–2021 · investors recorded per year
201912020120211
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Ribon Therapeutics?
Ribon Therapeutics has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Ribon Therapeutics last raise funding?
The most recent investment in Ribon Therapeutics recorded on gritt.io was in July 2021.
When was Ribon Therapeutics founded?
Ribon Therapeutics was founded in 2015.
What industry is Ribon Therapeutics in?
Ribon Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Ribon Therapeutics based?
Ribon Therapeutics is headquartered in Cambridge, United States.